Feb. 26 at 4:58 AM
$BSLK ... Biotech is having its beauty moment. 💄🧬
“Lab-grown.” “Bioengineered.” “Nature-identical.” These words are everywhere-- but “biotech” can mean very different things depending on whether you’re in a lab, a marketing meeting, or a supply-chain review.
Hype, Hope, or Greenwashed Science?”, we unpacked what’s real, what’s overstated, and why beauty can be a powerful first market for serious science and technology
▪️ What counts as biotech (and what doesn’t): Engineering microbes, plant cells, or enzymes to make molecules you can’t viably get from nature at scale—not just relabeling extracts and cold-pressed oils. 🧪
▪️ The true path from idea to ingredient: 5–10 years and anywhere from
$2-150M to go from proof-of-concept to breakeven volumes once you include R&D, clinicals, scale-up, and global regulatory.
▪️ Where projects really die: Less at discovery, more in the messy middle of scale-up, cost-down, and routine, high-quality manufacturing
